Dr. Richard Kenneth Yang, MD

Dr. Yang practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Yang's NPI, 1477971414, was assigned on April 5, 2014. Dr. Yang graduated from University of Wisconsin-Madison in 2014. Dr. Yang holds Texas license S6555.

Dr. Yang's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Dr. Yang's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. Dr. Yang is also affiliated with OU Health University of Oklahoma Medical Center. The medical group on file is Physicians Referral Service. Dmand AI also links Dr. Yang to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yang practices, 3 sites in all. Vendor and product names are available with a free account.

Molecular genetic pathology is Dr. Yang's primary specialty in the NPI Registry, under taxonomy code 207ZP0007X. Dr. Yang is board certified in pathology - anatomic/pathology - clinical by the American Board of Pathology. Dmand AI has Dr. Yang's licenses on file in 2 states: Texas and Wisconsin.

CMS data shows 1,127 Medicare services from Dr. Yang across 2 procedure codes in 2024, for 975 Medicare patients. Medicare paid $31,727 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 975 Medicare patients who saw Dr. Yang in 2024. The largest group is 65 to 74, with 566 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 2.05, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Yang's median patient age at 64, with 53% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Yang for performance year 2024, reported as part of a group. Dr. Yang accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 39 papers to Dr. Yang, published from 2010 to 2025. 2024 was the busiest year, with 6. The most frequent topics are Melanoma, Antibodies, Monoclonal and Biomarkers, Tumor. Dr. Yang has published most often in Cancer Immunol Immunother. Dr. Yang's most frequent co-authors are Paul M. Sondel, MD, PhD, Mark J. Routbort, MD, PhD and Woo Cheal Cho, MD.

CMS Open Payments shows 2 general payments to Dr. Yang from 1 drug or device company in 2022. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $136.

Dmand AI lists 13 awards for Dr. Yang, most recently Excellence in Teaching Award in Molecular Genetic Pathology in 2024.

Dr. Yang graduated from University of Wisconsin-Madison in 2014. Dr. Yang is a member of CAP.

Dr. Yang is in network with 7 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 5. Check the plan with the practice before a visit.